Dramatic Reversal of Lymphocytic Interstitial Pneumonitis in Sjögren’s Syndrome With Rituximab

Abstract

From the Divisions of *Pulmonary and Critical Care Medicine and †Rheumatology, Penn Presbyterian Medical Center, and ‡Penn Sjögren's Syndrome Center, University of Pennsylvania School of Medicine, Philadelphia,PA. No funding was received for this study. The authors declare no conflict of interest. Correspondence: Morris A. Swartz, MD, Division of Pulmonary and Critical Care Medicine, Penn Presbyterian Medical Center, 51 N 39th St, Philadelphia, PA 19104. E-mail: [email protected].